In a report published Friday, Morgan Stanley reiterates its Equal-Weight rating on WisdomTree Investments WETF, and raised its price target to $8.00.
Morgan Stanley noted, “The withdrawal of Research Affiliates' patent infringement lawsuit removes a significant overhang on WETF & returns the focus to organic growth. We're raising our normalized 2016 EPS estimate to 37c and price target to $8 after removing an assumed licensing fee settlement.”
WisdomTree Investments closed on Thursday at $6.21.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in